← Leaderboards
Zerui Wang
Case Western Reserve University
$1,495,421
Attributed
$5,981,684
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,981,684 · 2
By mechanism
R01$3,834,262 · 1
U01$2,147,422 · 1
Top collaborators
- Shu G Chen8 shared
- Allison L Kraus5 shared
- Bin Xu5 shared
- Steven A. Gunzler3 shared
- Qingzhong Kong3 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Witold K Surewicz$20,523,800
- Pierluigi Gambetti$33,097,698
- Shu G Chen$11,007,717
- Qingzhong Kong$9,304,366
- Neena Singh$9,545,188
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposPathologicAreaExhibitsMisfolded ProteinParkinson DiseaseCorticobasal DegenerationDepositionDiagnosisDiagnostic TestsCerebrospinal FluidBiological MarkersNeurodegenerative DisordersBiopsy SpecimenDetectionAlpha SynucleinAutopsyBrainAmyloid Beta-ProteinCreutzfeldt-Jakob SyndromeBrain TissueCadaverHypersensitivity Skin TestingPotential Biomarker
Grant awards (8)
Skin biomarkers for diagnosing and characterizing AD and ADRD$727,876
R01 · FY2025 · AG
Skin biomarkers for diagnosing and characterizing AD and ADRD$751,076
R01 · FY2024 · AG
Skin biomarkers for diagnosing and characterizing AD and ADRD$757,758
R01 · FY2023 · AG
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism$729,340
U01 · FY2023 · NS
Skin biomarkers for diagnosing and characterizing AD and ADRD$755,388
R01 · FY2022 · AG
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism$709,041
U01 · FY2022 · NS
Skin biomarkers for diagnosing and characterizing AD and ADRD$842,164
R01 · FY2021 · AG
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism$709,041
U01 · FY2021 · NS